Loading…
Association between multimorbidity, intensive care unit admission, and death in patients with COVID-19 in Brazil: a cross-section study, 2020
Multimorbidity can influence intensive care unit (ICU) admissions and deaths due to coronavirus disease (COVID-19). To analyze the association between multimorbidity, ICU admissions, and deaths due to COVID-19 in Brazil. This cross-sectional study was conducted using data from patients with severe a...
Saved in:
Published in: | São Paulo medical journal 2022, Vol.141 (3), p.e2022226-e2022226 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Multimorbidity can influence intensive care unit (ICU) admissions and deaths due to coronavirus disease (COVID-19).
To analyze the association between multimorbidity, ICU admissions, and deaths due to COVID-19 in Brazil.
This cross-sectional study was conducted using data from patients with severe acute respiratory syndrome (SARS) due to COVID-19 recorded in the Influenza Epidemiological Surveillance Information System (SIVEP-Gripe) in 2020.
Descriptive and stratified analyses of multimorbidity were performed based on sociodemographic, ventilatory support, and diagnostic variables. Poisson regression was used to estimate the prevalence ratios.
We identified 671,593 cases of SARS caused by COVID-19, of which 62.4% had at least one morbidity. Multimorbidity was associated with male sex, age 60-70 and ≥ 80 years, brown and black skin color, elementary education and high school, ventilatory support, and altered radiologic exams. Moreover, all regions of the country and altered computed tomography due to COVID-19 or other diseases were associated with death; only the northeast region and higher education were associated with ICU admission.
Our results showed an association between multimorbidity, ICU admission, and death in COVID-19 patients in Brazil. |
---|---|
ISSN: | 1516-3180 1806-9460 1806-9460 |
DOI: | 10.1590/1516-3180.2022.0226.R1.21072022 |